Repeating thinking tests about one year after the first test helps tell real brain change from testing quirks in people with MS.
Researchers followed 148 people with MS using thinking tests at the start, again about one year later, and then about six years after the start. Many people looked worse or better on the first test compared with the second, but most of those early changes were actually test-related and not true long-term change. After accounting for these practice and testing effects, scores tended to stay steady between the one-year check and the six-year check. Almost 40% of people who seemed impaired at the first test looked normal one year later, and about half looked normal at the long check, showing early results can be misleading. People who were normal at the one-year check usually stayed normal, and women and those who had improved by the one-year check were more likely to stay or become normal later on.
People with MS should care because this study shows a single test can sometimes give the wrong impression about thinking ability, like hearing a single cough and thinking someone has a cold. Caregivers can use this to avoid worrying over small early test changes and instead watch for patterns over time, like checking a child’s growth chart more than once. Healthcare providers can save time and money by repeating tests once after about a year for those who appeared impaired at first, and avoid unnecessary repeat tests for those who looked normal. If your first test says you are impaired, a follow-up test can confirm whether that was a true change or just a testing effect, similar to taking a second opinion. This helps decide who needs extra support, therapy, or monitoring, and who can be followed less closely.
This study does not prove why some people improve on repeat tests — practice effects, mood, or other factors may play a role, and the study could not control for every possible influence. The findings come from a specific group of 148 people and may not be exactly the same for every person with MS, especially those with different backgrounds or treatments. Also, the advice to repeat testing once mostly applies to people who look impaired on the first test and may not change care for those who are already normal.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More6/1/2026
Emerging MS therapies aim to slow long-term worsening, target a possible viral trigger, and repair n
Read More5/6/2026
Multiplexed MRI (MRx) measures many brain features at once to better describe MS tissue and lesions,
Read More5/6/2026
Study finds a multi-protein blood score reliably tracks disease activity in relapsing-remitting MS a
Read More5/6/2026
Study: Start with the κFLC index and add OCB only for middle results to accurately detect MS-related
Read More5/6/2026
Many people with MS report thinking problems. This study finds those complaints often tie to fatigue
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.